Cingulate Inc. (CING) Insider Trading & SEC Filings
Last SEC filing
Cingulate Inc. (CING) has filed 11 SEC Form 4 insider transactions in the last 90 days, with the most recent on 2026-07-20. Insiders disclosed 2 open-market purchases totaling $498K. 8 Form 8-K material event filings were reported by CING in the last 90 days. InsiderAlpha tracks every CING SEC filing - Form 4, Form 144, and 8-K - in real time, including Rule 10b5-1 plan detection.
About Cingulate Inc. (CING)
Cingulate Inc. trades under the ticker CING. InsiderAlpha tracks 33 primary SEC Form 4 filings from 11 reporting insiders for CING since 2024, sourced directly from SEC EDGAR.
| Sector | Health Care insider trading |
|---|---|
| SIC classification | Pharmaceutical Preparations (SIC 2834) |
| SEC CIK | 0001862150 |
90-Day SEC Filing Activity
| Insider purchases (90d) | 2 ($498K) |
|---|---|
| Form 4 filings (90d) | 11 |
| Form 8-K filings (90d) | 8 |
| Latest Form 4 filing | 2026-07-20 |
Recent CING Insider Transactions (Form 4)
| Date | Insider | Role | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Nilay Dahyabhai Patel | EVP, CLO and CCO | A - Grant or award | 5.5K | $0.00 | - | SEC | |
| Matthew Brams | EVP and Chief Medical Officer | F - Tax withholding / forfeiture | 1.0K | $0.00 | - | SEC | |
| Matthew Brams | EVP and Chief Medical Officer | A - Grant or award | 4.5K | $0.00 | - | SEC | |
| Nilay Dahyabhai Patel | EVP, CLO and CCO | F - Tax withholding / forfeiture | 2.1K | $0.00 | - | SEC | |
| Raul R. Silva | EVP and CSO | A - Grant or award | 4.5K | $0.00 | - | SEC | |
| Raul R. Silva | EVP and CSO | F - Tax withholding / forfeiture | 1.8K | $0.00 | - | SEC | |
| Shane J. Schaffer | Chief Executive Officer | A - Grant or award | 6.9K | $0.00 | - | SEC | |
| Shane J. Schaffer | Chief Executive Officer | F - Tax withholding / forfeiture | 3.0K | $0.00 | - | SEC | |
| Jennifer L. Callahan | EVP and CFO | A - Grant or award | 15.3K | $0.00 | - | SEC | |
| Jennifer L. Callahan | EVP and CFO | F - Tax withholding / forfeiture | 6.4K | $0.00 | - | SEC | |
| Thomas Jeffrey Hargroves | Director | P - Open-market purchase | 97.3K | $5.04 | $490K | SEC | |
| Shane J. Schaffer | Chief Executive Officer | P - Open-market purchase | 6.8K | $5.04 | $34K | SEC | |
| Matthew Brams | EVP and Chief Medical Officer | P - Open-market purchase | 1.9K | $5.04 | $10K | SEC | |
| Peter J. Werth | Director | P - Open-market purchase | 19.5K | $5.04 | $98K | SEC | |
| Jennifer L. Callahan | SVP and CFO | P - Open-market purchase | 4.9K | $5.04 | $25K | SEC |
All transactions sourced from SEC EDGAR Form 4 filings for Cingulate Inc. (CING). Updated in real time as new filings are submitted to the SEC.
Most-Active CING Insiders - Last 90 Days
| Insider | Form 4 filings | Total transaction value |
|---|---|---|
| Raul R. Silva | 4 | - |
| Thomas Jeffrey Hargroves | 4 | $498K |
| Jennifer L. Callahan | 2 | - |
| Shane J. Schaffer | 2 | - |
| Bryan Wade Downey | 2 | - |
Recent CING Form 8-K Material Events
- - Item 5.02 [SEC]
- - Item 5.02, 5.07, 9.01 [SEC]
- - Item 5.02, 7.01, 9.01 [SEC]
- - Item 7.01, 9.01 [SEC]
- - Item 7.01, 8.01, 9.01 [SEC]
Recent Insider Filings
- - Shane J. Schaffer (Chief Executive Officer)
- - Bryan Wade Downey (EVP & Chief Commercial Officer)
- - Bryan Jay Lawrence (Director)
- - Matthew Brams (EVP and Chief Medical Officer)
- - Thomas Jeffrey Hargroves (Director)
Form 4 Transaction Code Reference
SEC Form 4 transactions are reported with a one-letter code indicating the type of transaction. Common codes you'll see in CING insider filings:
| P | Open-market purchase by the insider |
|---|---|
| S | Open-market sale by the insider |
| A | Grant, award, or other acquisition from the issuer |
| M | Exercise or conversion of derivative security (e.g. options) |
| F | Payment of exercise price or tax liability via share withholding |
| G | Bona-fide gift of securities |
| D | Disposition to the issuer (e.g. share buyback participation) |
| J | Other acquisition or disposition |
| X | Exercise of in-the-money or at-the-money derivative security |
| C | Conversion of derivative security |
| V | Transaction voluntarily reported earlier than required |
CING Insider Trading - FAQ
- What is the latest insider trade for CING?
- Cingulate Inc. (CING) had 11 insider filings in the last 90 days, with the most recent on 2026-07-20. InsiderAlpha tracks every Form 4, Form 144, and 8-K filing in real time.
- How many insiders are buying CING stock?
- 2 insider purchases of CING were filed in the last 90 days, totaling $498K.
- How many insiders are selling CING stock?
- 0 insider sales of CING were filed in the last 90 days.
- Where can I see CING SEC filings (Form 4, 10-K, 10-Q, 8-K)?
- This page tracks CING Form 4 insider transactions, Form 144 sale notices, and 8-K material event disclosures in one timeline. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care Companies with Insider Activity
Other companies in the InsiderAlpha index with a significant SEC Form 4 insider-trading footprint:
- $CLRB Cellectar Biosciences, Inc.
- $COCH Envoy Medical, Inc.
- $COGT Cogent Biosciences, Inc.
- $CRSP CRISPR Therapeutics AG
- $CTTH CTT PHARMACEUTICAL HOLDINGS, INC.
- $CV CapsoVision, Inc
- $CVKD Cadrenal Therapeutics, Inc.
- $CVM CEL SCI CORP
- $DMAC DiaMedica Therapeutics Inc.
- $EDGM Edgemode, Inc.
Related Companies - Recent Insider Activity
- UNITED THERAPEUTICS Corp (UTHR)
- Liquidia Corp (LQDA)
- BeOne Medicines Ltd. (ONC)
- PERRIGO Co plc (PRGO)
- Processa Pharmaceuticals, Inc. (PCSA)
- Nuvalent, Inc. (NUVL)
- CYTOKINETICS INC (CYTK)
- Elanco Animal Health Inc (ELAN)
- Avalo Therapeutics, Inc. (AVTX)
- NATURES SUNSHINE PRODUCTS INC (NATR)
Learn More
- What is SEC Form 4?
- How to read insider buying signals
- Rule 10b5-1 trading plans explained
- The cluster buying signal
Open the live CING dashboard on InsiderAlpha for real-time alerts, charting, and full historical filing search.